Peritoneal dialysis should be considered as the first line of renal replacement therapy for most ESRD patients.
Burkart
J M
JM
Department of Internal Medicine, Wake Forest University Baptist Center, Winston-Salem, NC 27157-1053, USA. jburkart@wfubmc.edu
D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D019090:Case Management; D002408:Catheters, Indwelling; D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000517:prevention & control; D003928:Diabetic Nephropathies / Q000401:mortality / Q000628:therapy; D005260:Female; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000150:complications / Q000191:economics / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D010342:Patient Acceptance of Health Care; D010530:Peritoneal Dialysis / Q000191:economics; D011446:Prospective Studies; D011788:Quality of Life; D006435:Renal Dialysis / Q000191:economics; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome